Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

March 27, 2015 9:56 PM ET

Capital Markets

Company Overview of International Biotechnology Trust plc

Company Overview

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund’s assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of ...

71 Kingsway

London,  WC2B 6ST

United Kingdom

Founded in 1994


44 20 7421 7070


44 20 7421 7077

Key Executives for International Biotechnology Trust plc

Managing Partner
IBT Investment Manager
Finance Partner of Europe
Investment Manager
Age: 53
Lead Manager
Compensation as of Fiscal Year 2014.

International Biotechnology Trust plc Key Developments

International Biotechnology Trust plc Announces Audited Group Earnings Results for the Year Ended August 31, 2014

International Biotechnology Trust plc announced audited group earnings results for the year ended August 31, 2014. For the period, the company reported profit before finance costs and tax of £44,863,000 compared to £44,479,000 a year ago. profit on ordinary activities before tax was £44,754,000 compared to £44,466,000 a year ago. profit for the year attributable to owners of the parent company was £44,719,000 or 81.30 pence per basic and diluted share compared to £44,428,000 or 80.30 pence per basic and diluted share a year ago. Net cash flows used in operating activities were £2,231,000 compared to £21,000 a year ago.

International Biotechnology Trust Seeks Acquisitions

International Biotechnology Trust plc (LSE:IBT) is looking for acquisition opportunities. This has been a major driving force of mergers and acquisitions within the sector and is set to continue.

International Biotechnology Trust plc, Annual General Meeting, Nov 24, 2014

International Biotechnology Trust plc, Annual General Meeting, Nov 24, 2014., at 14:30 GMT Standard Time. Location: BNP Paribas Fortis.

Similar Private Companies By Industry

Company Name Region
Cowgill Holloway LLP, Corporate Finance Arm Europe
Amalgamated Metal Trading Limited Europe
UBS Limited Europe
Viatrade PLC Europe
Calimere Point Advisors Limited Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact International Biotechnology Trust plc, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at